INS-PRESCRIPTION DRUG BENEFITS House SponsorsRep. Greg Harris-Marcus C. Evans, Jr.-Debbie Meyers-Martin-Nicholas K. Smith, Theresa Mah, Dagmara Avelar, Jonathan Carroll, Joyce Mason, Stephanie A. Kifowit, Sue Scherer, Will Guzzardi, Mark L. Walker, Daniel Didech, Kelly M. Cassidy, Martin J. Moylan, Anne Stava-Murray, Michelle Mussman, William Davis, Bob Morgan, Rita Mayfield, Margaret Croke, Deb Conroy, Maura Hirschauer, Katie Stuart, Lindsey LaPointe, Thaddeus Jones, Anthony DeLuca, Michael Halpin, Suzanne Ness, Elizabeth Hernandez, Dave Vella, Emanuel Chris Welch and Janet Yang Rohr Senate Sponsors(Sen. Napoleon Harris, III, Antonio Muņoz-Mike Simmons, Laura Fine-Thomas Cullerton, Ram Villivalam-Michael E. Hastings-Scott M. Bennett, Adriane Johnson, Meg Loughran Cappel, Julie A. Morrison, David Koehler, Doris Turner, Jacqueline Y. Collins, Bill Cunningham, Laura M. Murphy, Melinda Bush, Sara Feigenholtz and Patricia Van Pelt) 8/16/2021HousePublic Act . . . . . . . . . 102-0391 215 ILCS 134/45.3 new Amends the Managed Care Reform and Patient Rights Act. Requires health insurance carriers that provide coverage for prescription drugs to ensure that, within service areas and levels of coverage specified by federal law, at least half of individual and group plans meet one or more of the following criteria: apply a pre-deductible and flat-dollar copayment structure to the entire drug benefit, limit a beneficiary's monthly out-of-pocket financial responsibility for prescription drugs to a specified amount, or limit a beneficiary's annual out-of-pocket financial responsibility for prescription drugs to a specified amount. Provides that all plans for prescription drugs offered under the amendatory Act must be clearly and appropriately named, marketed in the same manner as other plans offered by the health insurance carrier, and offered for purchase to any individual and group plan sponsor. Effective January 1, 2022.House Committee Amendment No. 1 Replaces everything after the enacting clause. Amends the Managed Care Reform and Patient Rights Act. In provisions concerning individual health plans that provide coverage for prescription drugs, provides that beginning January 1, 2023, health insurance carriers shall ensure that at least 10% of individual health care plans offered in each applicable service area apply a flat-dollar copayment structure to the entire drug benefit; and beginning January 1, 2024, health insurance carriers shall ensure that at least 25% of individual health care plans offered in each applicable service area apply a flat-dollar copayment structure to the entire drug benefit. In provisions concerning group health plans that provide coverage for prescription drugs, provides that beginning January 1, 2023, health insurance carriers shall offer at least one group health plan in each applicable service area that applies a flat-dollar copayment structure to the entire drug benefit; and beginning January 1, 2024, health insurance carriers shall offer at least 2 group health plans in each applicable service area that apply a flat-dollar copayment structure to the entire drug benefit. Provides that the flat-dollar copayment structure for prescription drugs must be applied pre-deductible and be reasonably graduated and proportionately related in all tier levels such that the copayment structure as a whole does not discriminate against or discourage the enrollment of individuals with significant health care needs. Requires the health insurance carriers to clearly and appropriately name the plans to aid in individual or group plan selection. Requires the health insurance carriers to market the plans in the same manner as their other plans. Requires the Department of Insurance to adopt rules necessary to implement and enforce the provisions. Effective January 1, 2023. 2/11/2021HouseFiled with the Clerk by Rep. Greg Harris 2/16/2021HouseAdded Co-Sponsor Rep. Theresa Mah 2/16/2021HouseAdded Co-Sponsor Rep. Dagmara Avelar 2/16/2021HouseAdded Co-Sponsor Rep. Jonathan Carroll 2/16/2021HouseAdded Co-Sponsor Rep. Joyce Mason 2/16/2021HouseAdded Co-Sponsor Rep. Stephanie A. Kifowit 2/16/2021HouseAdded Co-Sponsor Rep. Sue Scherer 2/17/2021HouseFirst Reading 2/17/2021HouseReferred to Rules Committee 2/26/2021HouseAdded Co-Sponsor Rep. Will Guzzardi 2/26/2021HouseAdded Chief Co-Sponsor Rep. Marcus C. Evans, Jr. 2/26/2021HouseAdded Co-Sponsor Rep. Mark L. Walker 2/26/2021HouseAdded Co-Sponsor Rep. Daniel Didech 2/26/2021HouseAdded Co-Sponsor Rep. Kelly M. Cassidy 2/26/2021HouseAdded Co-Sponsor Rep. Martin J. Moylan 2/26/2021HouseAdded Co-Sponsor Rep. Anne Stava-Murray 2/28/2021HouseAdded Co-Sponsor Rep. Michelle Mussman 3/2/2021HouseAdded Co-Sponsor Rep. William Davis 3/2/2021HouseAdded Co-Sponsor Rep. Bob Morgan 3/4/2021HouseAdded Co-Sponsor Rep. Rita Mayfield 3/8/2021HouseAdded Co-Sponsor Rep. Margaret Croke 3/9/2021HouseAssigned to Prescription Drug Affordability & Accessibility Committee 3/12/2021HouseAdded Chief Co-Sponsor Rep. Debbie Meyers-Martin 3/12/2021HouseAdded Co-Sponsor Rep. Deb Conroy 3/12/2021HouseAdded Co-Sponsor Rep. Maura Hirschauer 3/17/2021HouseAdded Co-Sponsor Rep. Katie Stuart 3/18/2021HouseAdded Co-Sponsor Rep. Lindsey LaPointe 3/19/2021HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Greg Harris 3/19/2021HouseHouse Committee Amendment No. 1 Referred to Rules Committee 3/22/2021HouseAdded Co-Sponsor Rep. Thaddeus Jones 3/23/2021HouseHouse Committee Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee 3/25/2021HouseHouse Committee Amendment No. 1 Adopted in Prescription Drug Affordability & Accessibility Committee; by Voice Vote 3/25/2021HouseDo Pass as Amended / Consent Calendar Prescription Drug Affordability & Accessibility Committee; 018-000-000 3/30/2021HouseAdded Co-Sponsor Rep. Anthony DeLuca 4/8/2021HousePlaced on Calendar 2nd Reading - Consent Calendar 4/12/2021HouseAdded Co-Sponsor Rep. Michael Halpin 4/14/2021HouseSecond Reading - Consent Calendar 4/14/2021HouseHeld on Calendar Order of Second Reading - Consent Calendar 4/14/2021HousePlaced on Calendar Order of 3rd Reading - Consent Calendar 4/16/2021HouseThird Reading - Consent Calendar - First Day 4/20/2021HouseAdded Co-Sponsor Rep. Suzanne Ness 4/20/2021HouseAdded Co-Sponsor Rep. Elizabeth Hernandez 4/20/2021HouseAdded Co-Sponsor Rep. Dave Vella 4/20/2021HouseAdded Co-Sponsor Rep. Emanuel Chris Welch 4/20/2021HouseAdded Chief Co-Sponsor Rep. Nicholas K. Smith 4/21/2021HouseAdded Co-Sponsor Rep. Janet Yang Rohr 4/21/2021HouseThird Reading - Consent Calendar - Passed 117-000-000 4/21/2021SenateArrive in Senate 4/21/2021SenatePlaced on Calendar Order of First Reading April 22, 2021 4/22/2021SenateChief Senate Sponsor Sen. Napoleon Harris, III 4/22/2021SenateFirst Reading 4/22/2021SenateReferred to Assignments 4/28/2021SenateAdded as Alternate Co-Sponsor Sen. Antonio Muņoz 4/29/2021SenateAdded as Alternate Chief Co-Sponsor Sen. Mike Simmons 4/29/2021SenateAdded as Alternate Co-Sponsor Sen. Laura Fine 5/3/2021SenateAdded as Alternate Chief Co-Sponsor Sen. Thomas Cullerton 5/3/2021SenateAdded as Alternate Co-Sponsor Sen. Ram Villivalam 5/3/2021SenateAdded as Alternate Chief Co-Sponsor Sen. Michael E. Hastings 5/3/2021SenateAdded as Alternate Chief Co-Sponsor Sen. Scott M. Bennett 5/4/2021SenateAssigned to Insurance 5/4/2021SenateAdded as Alternate Co-Sponsor Sen. Adriane Johnson 5/4/2021SenateAdded as Alternate Co-Sponsor Sen. Meg Loughran Cappel 5/4/2021SenateAdded as Alternate Co-Sponsor Sen. Julie A. Morrison 5/5/2021SenateAdded as Alternate Co-Sponsor Sen. David Koehler 5/5/2021SenateAdded as Alternate Co-Sponsor Sen. Doris Turner 5/5/2021SenateAdded as Alternate Co-Sponsor Sen. Jacqueline Y. Collins 5/6/2021SenateAdded as Alternate Co-Sponsor Sen. Bill Cunningham 5/6/2021SenateAdded as Alternate Co-Sponsor Sen. Laura M. Murphy 5/13/2021SenateDo Pass Insurance; 011-000-000 5/13/2021SenatePlaced on Calendar Order of 2nd Reading May 14, 2021 5/13/2021SenateAdded as Alternate Co-Sponsor Sen. Melinda Bush 5/14/2021SenateSecond Reading 5/14/2021SenatePlaced on Calendar Order of 3rd Reading May 17, 2021 5/21/2021SenateAdded as Alternate Co-Sponsor Sen. Sara Feigenholtz 5/24/2021SenatePlaced on Calendar Order of 3rd Reading ** May 25, 2021 5/26/2021SenateAdded as Alternate Co-Sponsor Sen. Patricia Van Pelt 5/27/2021SenateThird Reading - Passed; 057-000-000 5/27/2021HousePassed Both Houses 6/23/2021HouseSent to the Governor 8/16/2021HouseGovernor Approved 8/16/2021HouseEffective Date January 1, 2023 8/16/2021HousePublic Act . . . . . . . . . 102-0391